Impact of Achieving ASDAS LDA on Disease Activity and Patient-Reported Outcome Measures Among Patients with Ankylosing Spondylitis Treated with Biologic DMARDs - ACR Meeting Abstracts

Background/Purpose: Although Ankylosing Spondylitis Disease Activity Score (ASDAS) low disease activity (LDA) is a common treatment target for disease control when managing AS, real-world research describing ASDAS LDA achievement among patients treated with biologic DMARDs (bDMARD) is limited. The aim of this study was to describe disease activity and patient-reported outcome measures (PROMs) among patients […]

Disease activity measurements and monitoring in psoriatic

The state of the art—psoriatic arthritis outcome assessment in

Canadian Rheumatology Association Meeting Quebec City Convention

Which Disease Activity Outcome Measure Discriminates Best in Axial

Safety Profile, Axial Spondyloarthritis

PDF) Golimumab as the First-, Second-, or at Least Third-Line

ACR Convergence 2022

PDF) AB0002 Sirt-1 Activity in PBMC from Patients with

Effect of body mass index on treatment response of biologic